Article Text

Download PDFPDF
Dilate or wait for effective anti-inflammatory treatment for stenotic lesions associated with active inflammatory signs in Crohn's disease
  1. Yucel Ustundag1,
  2. Ahmet Tezel2
  1. 1Zonguldak Karaelmas University School of Medicine, Department of Gastroenterology Kozlu-Zonguldak, Turkey
  2. 2Trakya University, School of Medicine, Department of Gastroenterology, Edirne, Turkey
  1. Correspondence to Yucel Ustundag, Zonguldak Karaelmas University School of Medicine, Department of Gastroenterology, Kozlu-Zonguldak 67600, Turkey; yucel_u{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We read with interest the article by Assche1 et al regarding the long-term outcomes of endoscopic dilatation in 133 patients with Crohn's disease exhibiting ileal, ileocolonic and anastomotic strictures, on a retrospective basis. They performed multistep dilatation utilising scope balloons starting from 15–16.5 cm and widening to 18 cm at the maximal diameter. They concluded that endoscopic balloon dilatation is an effective method with long-term relief of symptomatology in 54% of patients, without a need for repeat dilatation or surgery in 76% of patients after the first dilatation. They reported the occurrence of 12 (5.1%) serious adverse events in 237 dilatations. They underlined the fact that neither active inflammation at the site of stricture, high serum C-reactive protein levels nor …

View Full Text


  • Competing interests None.

  • Provenance and peer review Not commissioned; not externally peer reviewed.

Linked Articles

  • PostScript
    Clara Thienpont Séverine Vermeire Paul Rutgeerts Gert Van Assche